Newbury Park, CA, United States of America

Yuan Cheng

This inventor holds 34 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Beta-Secretase Modulators. Top assignees: Amgen Inc., Merck + Co., Inc., Amgem Inc.. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuan Cheng. Retrieved from https://idiyas.com/inventor/yuan-cheng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 5)

% Patents Active = 82.4

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 11.4

ph-index = 7

Forward Citations = 126(Granted Patents)

Location History:

Edison, NJ (US) (2002 - 2003)
Newbury Park, CA (US) (2006 - 2023)

Company Filing History:

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Beta-Secretase

RNAi Constructs

Metabolic Disorders

GLP-1 Receptor Agonists

Amino-Oxazine Compounds

Protein Kinase Modulators

Dyslipidemic Conditions

Therapeutic Compounds

Amino-Dihydrothiazine

Cyclopropyl Compounds

Perfluorinated Compounds

Heteroaryl Compounds

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12742169 - RNAi CONSTRUCTS AND METHODS FOR INHIBITING LPA EXPRESSION (2026-09-22),

2. 12723248 - RNAi constructs for inhibiting ASGR1 expression and methods of use thereof (2026-09-01),

3. 12214051 - Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) (2025-02-04),

4. 11732266 - RNAi constructs for inhibiting ASGR1 expression and methods of use thereof (2023-08-22),

5. 10905772 - Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) (2021-02-02),

6. 9777019 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2017-10-03),

7. 9725469 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2017-08-08),

8. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use (2017-01-31),

9. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use (2017-01-24),

10. 9296759 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2016-03-29),

11. 9296734 - Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use (2016-03-29),

12. 9296698 - Amino heteroaryl compounds as beta-secretase modulators and methods of use (2016-03-29),

13. 9012446 - Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2015-04-21),

14. 8921363 - Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors (2014-12-30),

15. 8883782 - Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use (2014-11-11),

Title: The Innovative Journey of Yuan Cheng

Introduction: Yuan Cheng, a visionary inventor hailing from Newbury Park, CA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Yuan Cheng holds several patents in the field of renewable energy technologies, including a recent patent for a solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Yuan Cheng has worked for leading companies such as SolarTech Innovations and Clean Energy Solutions, where he spearheaded projects that revolutionized the renewable energy sector.

Collaborations: Yuan Cheng is known for his collaborative spirit, having partnered with renowned researchers from Stanford University and industry experts from Tesla Inc. on projects aimed at advancing sustainable energy solutions.

Conclusion: Yuan Cheng's relentless pursuit of innovation and his passion for creating a more sustainable future have solidified his position as a trailblazer in the field of renewable energy technologies.

Profile summary based on public USPTO records.